Caregen Selected for Full-Cycle Medical Device R&D Project

[Asia Economy Reporter Minji Lee] Caregen announced on the 26th that it has been finally selected for the 2nd phase of the Pan-Ministerial Jeonju Medical Device R&D Project this year. The project is related to the development and approval of implantable medical devices applying customized peptide materials, with a support budget of 3.85 billion KRW.

The company stated, "The task is 'Development and approval of implantable medical devices applying customized peptide materials,' aiming to develop implantable medical devices with excellent regenerative ability and secured safety using original technology bioactive peptides, and to obtain domestic and global approvals (US FDA) for the medical device products as the final goal."

This content was produced with the assistance of AI translation services.